Kornitzer Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-244,679
Closed -$11.1M 509
2021
Q4
$11.1M Buy
244,679
+58,355
+31% +$3.05M 0.17% 207
2021
Q3
$11.8M Sell
186,324
-56,850
-23% -$4.33M 0.18% 208
2021
Q2
$22.3M Sell
243,174
-24,805
-9% -$1.97M 0.33% 107
2021
Q1
$18.2M Sell
267,979
-46,460
-15% -$3.61M 0.29% 124
2020
Q4
$22.8M Sell
314,439
-146,038
-32% -$8.46M 0.39% 81
2020
Q3
$17.5M Sell
460,477
-5,945
-1% -$201K 0.34% 92
2020
Q2
$16.5M Sell
466,422
-4,130
-0.9% -$118K 0.33% 106
2020
Q1
$10.3M Buy
470,552
+42,192
+10% +$945K 0.24% 140
2019
Q4
$9.24M Buy
428,360
+17,550
+4% +$403K 0.16% 183
2019
Q3
$9.29M Buy
410,810
+101,155
+33% +$2.8M 0.17% 177
2019
Q2
$11.1M Buy
309,655
+69,535
+29% +$2.23M 0.2% 156
2019
Q1
$7.57M Sell
240,120
-250
-0.1% -$7.28K 0.14% 203
2018
Q4
$6.04M Buy
+240,370
New +$6.18M 0.12% 211

Other funds holding CDNA

Kornitzer Capital Management's CDNA Position: Q1 2022 in Review

Kornitzer Capital Management sold out of CareDx (CDNA) in Q1 2022, closing a stake of 244,679 shares — an estimated $11.1M sold.

Kornitzer Capital Management first reported a position in CDNA in Q4 2018 and held it in 13 quarters. The position peaked at $22.8M in Q4 2020. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.

  • Kornitzer Capital Management reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
  • Kornitzer Capital Management sold 244,679 CareDx shares in Q1 2022, an estimated $11.1M.
  • Kornitzer Capital Management first reported a position in CareDx in Q4 2018 and held it in 13 quarters.
  • Kornitzer Capital Management's CareDx position peaked at $22.8M in Q4 2020.
  • 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.

Based on Kornitzer Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.